Conference Coverage

Personal omics profiling here to stay

Publish date: December 21, 2017

 

EXPERT ANALYSIS FROM WCIRDC 2017

He disclosed that he is a scientific adviser to Personalis, Genapsys, SensOmics, and Qbio.

dbrunk@frontlinemedcom.com

Pages

Recommended Reading

Does incretin therapy increase pancreatic cancer risk?
MDedge Endocrinology
Empagliflozin’s heart failure benefits linked to volume drop
MDedge Endocrinology
Intranasal insulin, ketogenic diet may benefit Alzheimer’s patients
MDedge Endocrinology
FDA approves injectable diabetes drug that improves A1c scores
MDedge Endocrinology
Health disparities in rural America: Chronic conditions
MDedge Endocrinology
Expert discusses the role of salt and fructose in diabetes
MDedge Endocrinology
Type 2 diabetes remitted with low-calorie diet
MDedge Endocrinology
FDA approves first follow-on short-acting insulin product using abbreviated approval pathway
MDedge Endocrinology
ADA guidelines embrace heart health
MDedge Endocrinology
Link between glucose control and CVD risk: It’s complicated
MDedge Endocrinology